Medtronic (MDT) Receivables - Net (2014 - 2026)

Medtronic (MDT) has 13 years of Receivables - Net data on file, last reported at $6.6 billion in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Net rose 1.96% year-over-year to $6.6 billion; the trailing twelve-month figure through Apr 2026 stood at $6.6 billion (up 1.96% YoY), and the FY2026 full-year result was $6.6 billion, up 1.96% from the prior year.
• Receivables - Net climbed to $6.6 billion in Q2 2026, from $6.4 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $6.6 billion in Q2 2026 to a low of $5.3 billion in Q3 2022.
• A 5-year average of $6.0 billion and a median of $6.0 billion in 2023 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net decreased 2.26% in 2022 and climbed 9.38% in 2023, its largest moves.
• Tracing MDT's Receivables - Net over 5 years: stood at $5.6 billion in 2022, then rose by 5.47% to $5.9 billion in 2023, then gained by 5.49% to $6.3 billion in 2024, then climbed by 2.06% to $6.4 billion in 2025, then rose by 3.98% to $6.6 billion in 2026.
• Business Quant data shows MDT's Receivables - Net at $6.6 billion in Q2 2026, $6.4 billion in Q1 2026, and $6.4 billion in Q4 2025.